Yahoo · Nov 13, 2026
NextPlat (NXPL) Q3 2026 Earnings Call Transcript
Healthcare margins rose sharply while total revenue fell year over year.
NASDAQ · NXPL
Technology · Software - Application
$7.02
Up+$0.33 (+4.93%)
Updated Nov 15, 2026, 6:20 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NXPL
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
NXPL closed at $7.02 after 20 trading sessions, down 22.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $6.90 | $7.42 | $6.35 | $7.02 | 28.74K |
| Nov 12, 2026 | $7.50 | $7.50 | $5.8597 | $6.69 | 52.96K |
| Nov 11, 2026 | $8.455 | $8.63 | $7.80 | $8.29 | 27.06K |
| Nov 10, 2026 | $8.5287 | $8.69 | $8.3099 | $8.35 | 8.94K |
| Nov 9, 2026 | $8.34 | $8.79 | $7.88 | $8.79 | 7.14K |
| Nov 6, 2026 | $7.52 | $8.34 | $7.52 | $8.24 | 12.44K |
| Nov 5, 2026 | $8.07 | $8.08 | $6.88 | $7.59 | 31.69K |
| Nov 4, 2026 | $8.45 | $8.66 | $7.9409 | $8.05 | 33.29K |
| Nov 3, 2026 | $8.5916 | $8.60 | $8.00 | $8.05 | 13.82K |
| Nov 2, 2026 | $8.28 | $8.39 | $8.00 | $8.30 | 31.84K |
| Oct 30, 2026 | $8.39 | $8.79 | $7.91 | $8.11 | 25.33K |
| Oct 29, 2026 | $8.36 | $8.64 | $8.165 | $8.30 | 10.11K |
| Oct 28, 2026 | $8.8755 | $9.05 | $8.36 | $8.50 | 15.47K |
| Oct 27, 2026 | $8.36 | $8.80 | $8.2598 | $8.62 | 12.6K |
| Oct 26, 2026 | $8.80 | $8.80 | $8.35 | $8.46 | 13.02K |
| Oct 23, 2026 | $8.51 | $9.05 | $8.30 | $8.50 | 43.77K |
| Oct 22, 2026 | $8.90 | $8.90 | $8.4208 | $8.65 | 34.29K |
| Oct 21, 2026 | $8.80 | $9.49 | $7.93 | $8.61 | 37.15K |
| Oct 20, 2026 | $8.98 | $9.49 | $8.60 | $9.045 | 18.02K |
| Oct 19, 2026 | $9.25 | $9.50 | $8.50 | $9.0993 | 15.19K |
The latest Smart Investors Daily articles mentioning NXPL.
Company
Market Activity
Research & News
NXPL research
Company profile and research snapshot.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 24, 2026 | Litchfield Hills | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 13, 2026
Healthcare margins rose sharply while total revenue fell year over year.
Yahoo · Nov 12, 2026
NextPlat Corp (NXPL) lifted gross margin to 35% and cut its operating loss by nearly 65% as contracted pharmacy revenue surged almost 300%, even as total revenues fell to $10.5 million.
Yahoo · Nov 12, 2026
NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced operating results for the third quarter ended September 30, 2026.
Benzinga · Nov 12, 2026
NextPlat (NASDAQ:NXPL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NXPL.